Press Releases

Home > Press Releases

Press Releases (Page 87)

ACHC STOCK ALERT: Why is Acadia Healthcare being Sued for Securities Fraud? Investors that Lost Money are Notified to Contact BFA Law by December 16 Deadline (Nasdaq:ACHC)

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. ... ❯❯❯

DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DexCom, Inc. (NASDAQ: DXCM) on behalf of long-term stockholders following a class action complaint that was filed against DexCom on August 21, 2024 with a Class Period from April 28, 2023 to July 25, 2024. Our investigation concerns whether the board of directors of... ❯❯❯

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, Starbucks, Endava, and Sage and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Methode Electronics Inc. (NYSE: MEI), Starbucks Corporation (NASDAQ:SBUX), Endava PLC (NYSE: DAVA), and Sage Therapeutics, Inc. (NASDAQ: SAGE). Stockholders have until the deadlines below to petition the court to serve as... ❯❯❯

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AMMO, Paragon 28, Iris Energy, and Terran and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of AMMO, Inc. (NASDAQ: POWW), Paragon 28, Inc. (NYSE: FNA), Iris Energy Limited (NASDAQ: IREN), and Terran Orbital (NYSE: LLAP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.... ❯❯❯

LUNA INNOVATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (NASDAQ: LUNA) on behalf of long-term stockholders following a class action complaint that was filed against Luna Innovation on April 1, 2024 with a Class Period from August 11, 2023 to March 25, 2024. Our investigation concerns whether the board... ❯❯❯

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Outset Medical, ZoomInfo, and Super Micro and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of GitLab Inc. (NASDAQ: GTLB), Outset Medical, Inc. (NASDAQ: OM), ZoomInfo Technologies Inc. (NASDAQ: ZI), and Super Micro Computer, Inc. (NASDAQ: SMCI). Stockholders have until the deadlines below to petition the court to serve... ❯❯❯

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Agenus, and New Fortress and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR), Metagenomi, Inc. (NASDAQ: MGX), Agenus Inc. (NASDAQ: AGEN), and New Fortress Energy Inc. (NASDAQ:NFE). Stockholders have until the deadlines below to petition the court to serve as... ❯❯❯

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acadia Healthcare, WM Technology, and Xiao-I and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acadia Healthcare Company, Inc. (NASDAQ: ACHC), WM Technology, Inc. (NASDAQ: MAPS), and Xiao-I Corporation (NASDAQ: AIXI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.... ❯❯❯

MGP ALERT: Bragar Eagel & Squire, P.C. is Investigating MGP Ingredients, Inc. on Behalf of MGP Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against MGP Ingredients, Inc. (“MGP” or the “Company”) (NASDAQ: MGPI) on behalf of MGP stockholders. Our investigation concerns whether MGP has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action.... ❯❯❯

ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ardelyx, Inc. (NASDAQ: ARDX) on behalf of long-term stockholders following a class action complaint that was filed against Ardelyx on August 16, 2024, with a Class Period from October 31, 2023 to July 1, 2024. Our investigation concerns whether the board of directors... ❯❯❯